Clinical recommendations for treating and monitoring patients with renal cancer
Petković, M.; Vrdoljak, E.; Ruzić, I.Pavlović.; Belev, B.; Omrcen, T.; Ledina, D.; Tomek, R.; Ruzić, B.; Situm, M.; Buća, A.; Pisac, V.Pesutić.
Lijecnicki Vjesnik 134(1-2): 5-8
2012
ISSN/ISBN: 0024-3477 PMID: 22519246 Document Number: 657490
Clear cell renal carcinoma is the most common kidney cancer. It is generally asymptomatic. A small percentage of patients present with hematuria, flank pain and abdominal mass. It is usually detected accidentally during radiologic examination. The diagnosis of kidney cancer is confirmed by pathohistological findings after completion of the diagnostic process. The decision about treatment is made based on clinical assessment of disease stage and other risk factors. Depending on that, treatment options include surgery, and considering high resistance of kidney cancer on chemotherapy and hormone therapy, use of targeted therapies (immunotherapy, tyrosine kinase inhibitors) and palliative radiotherapy. The following text presents the clinical guidelines in order to standardize procedures and criteria for the diagnosis, management, treatment and monitoring of patients with kidney cancer in the Republic of Croatia.